Treatment of sleep dysfunction and psychiatric disorders

@article{Becker2009TreatmentOS,
  title={Treatment of sleep dysfunction and psychiatric disorders},
  author={Philip M. Becker},
  journal={Current Treatment Options in Neurology},
  year={2009},
  volume={8},
  pages={367-375}
}
  • P. Becker
  • Published 2009
  • Psychology, Medicine
  • Current Treatment Options in Neurology
Opinion statementPatients with neurologic disorders commonly experience sleep dysfunction and psychiatric disorders. The most common sleep dysfunction is insomnia, which is a primary symptom in 30% to 90% of psychiatric disorders. Insomnia and fatigue are prominent symptoms of anxiety disorders and major depression, including patients who are treated but have residual symptoms. Anxiety and depressive disorders account for 40% to 50% of all cases of chronic insomnia. It is also recognized that… 

Schlafstörungen im Alter

Recognition of a sleep disorder and its diagnostic classification may be of major relevance, especially in the elderly, and particular importance attaches to chronobiological procedures for optimisation of day–night contrasting.

Sleep America: managing the crisis of adult chronic insomnia and associated conditions.

Sex Differences in Subjective Sleep Quality Patterns in Schizophrenia

Female patients were more likely to report being poor sleepers and endorsed more sleep disturbances than female HC, while male patients reported longer sleep duration, more daytime dysfunction, and poorer overall sleep quality relative to male HC.

Innovations in Practice: The relationship between sleep disturbances, depression, and interpersonal functioning in treatment for adolescent depression

Investigation of the effect of sleep disturbance in depressed adolescents treated with Interpersonal Psychotherapy for Adolescents versus Treatment as Usual in school-based mental health clinics suggests that sleep disturbance should be a target for future treatment development research among depressed adolescents.

The complex role of sleep in adolescent depression.

  • G. ClarkeA. Harvey
  • Psychology
    Child and adolescent psychiatric clinics of North America
  • 2012

Hypnotics in insomnia: the experience of zolpidem.

Quetiapine: treatment for substance abuse and drug of abuse.

  • M. HanleyG. A. Kenna
  • Psychology, Medicine
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2008
Small-scale studies provide some evidence that quetiapine may benefit patients diagnosed with a mental illness who are also dependent on cocaine, amphetamines, or both, though more rigorous studies are needed.

Lack of Sleep in the Workplace: What the Psychologist-Manager Should Know About Sleep

Lack of sleep and/or untreated sleep disorders have serious consequences for productivity, safety, health, and quality of life. Despite this, sleep needs tend to be ignored by American culture in

Electroencephalographic power spectral density profile of the orexin receptor antagonist suvorexant in patients with primary insomnia and healthy subjects.

It is suggested that antagonism of the orexin pathway might lead to improvements in sleep without major changes in the patient's neurophysiology as assessed by electroencephalographic, and suvorexant at clinically effective doses had limited effects on power spectral density.